Understanding how certain immune cells fight fungal infections in patients with weakened immune systems
Novel mechanisms of Alveolar Macrophage-Dependent Antifungal Innate Immunity
This study is looking at how certain immune cells in the lungs help fight off a serious lung infection called Pneumocystis pneumonia in people with weakened immune systems, like those with AIDS, to find out why some people can resist the infection better than others and to improve treatments for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10746803 on NIH RePORTER |
What this research studies
This research investigates the role of alveolar macrophages, a type of immune cell in the lungs, in fighting Pneumocystis pneumonia (PcP), a serious fungal infection that affects immunocompromised patients, particularly those with AIDS. The study aims to uncover the mechanisms by which these immune cells recognize and eliminate the fungus, especially in the absence of T cells, which are often depleted in these patients. By examining different macrophage phenotypes, the research seeks to identify why some individuals can resist infection while others cannot, potentially leading to improved treatment strategies. The findings could help refine the use of corticosteroids and other therapies to enhance patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are immunocompromised individuals, particularly those living with AIDS or other conditions that weaken the immune system.
Not a fit: Patients with strong immune systems or those not affected by Pneumocystis pneumonia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for Pneumocystis pneumonia, reducing mortality rates among immunocompromised patients.
How similar studies have performed: Previous research has shown promise in understanding immune responses to fungal infections, but this specific approach focusing on alveolar macrophages in the context of Pneumocystis pneumonia is relatively novel.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Wright, Terry W — University of Rochester
- Study coordinator: Wright, Terry W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.